Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2017-A02618-45 | Other Identifier | ID RCB |
Not provided
Not provided
few patient feedback and principal investigator disponibility
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The CBSM is a program combining cognitive and behavioral therapies, relaxation provided in groups of 8 to 10 patients. This program has demonstrated benefits in stress management skills, adaptive strategies, anxiety, quality of life, social inclusion, medication adherence, depression, therapeutic alliance, and general well-being. It would also improve breast cancer survival after adjuvant therapy. This program has been put in place at the center of pain for patients with cancer pain in any stage. This study aims to evaluate the benefits of this technique on a patient population suffering from chronic pain related to cancer.
Methodology: Observational study, prospective, open, mono-centric, comparative, evaluating a psychosocial intervention type CBSM versus no intervention (group "waiting list").
Main Objective: To evaluate the impact of the implementation of a "CBSM" program on the stress management capacities of a pilot group of 30 patients followed at the pain center of Grenoble-Alpes University Hospital for chronic pain related to cancer or its treatment, compared to a control group "waiting list"
Primary Outcome: Measurement of emotional stress (PSS14)
Secondary objective:
Determine patients' interest in this program and the feasibility of the program.
Determine patient satisfaction with this program To evaluate the impact of the program on the quality of life of patients. To evaluate the impact of the program on the handicap perceived by the patients in connection with their pains.
Evaluation of the impact of the program on the pain of the patients (on the daily behavior).
Evaluation of the impact of the program on depression and anxiety. Determine the impact of the 3-month program of the 9th session on the different dimensions described above
Inclusion criterion:
Criteria of non-inclusion:
Number of patients included: a minimum of 30 patients including, a minimum of 15 in the CBSM group and a minimum of 15 in the "waiting list" group (patients included in the waiting list group will participate in the CBSM program but will not be not analyzed in the CBSM group)
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CBSM | Patients included in this group participate in the CBSM program. They attend 10 sessions of stress management according to the CBSM program, 9 take place over 3 months and the tenth session takes place 3 months after the 9th session. The session is composed of relaxation and cognitive and behavioral therapy, which is carried out in groups of 8 to 10 patients |
| |
| Waiting list | The CBSM group is compared to the "waiting list" group that does not benefit from the CBSM program. After completing their assessment in the "waiting list" group, patients in this group will be integrated into the CBSM group but will not be evaluated as such. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cognitive behavioral stress management | Other | Management of patients in 10 group sessions with cognitive and behavioral therapies associated with relaxation in order to learn how to manage stress |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of emotional stress (PSS14) | assessment of the evolution of stress over a period of 3 months: Questionnaire PSS14 | evaluation at the beginning of the meeting and at 9 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Inclusion rate | ratio of number of patients who agreed to participate in the program to the number of patients to whom the program was proposed | up to 18 months |
| Satisfaction | Satisfaction rate of CBSM program with a questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patient being treated for cancer, undergoing treatment or having completed treatment, at any stage and suffering from chronic pain
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Claudine BERTHOZAT, MD | pain center, Grenoble University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Grenoble University Hospital | La Tronche | Isère | 30700 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059350 | Chronic Pain |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| at 6 months |
| Measurement of quality of life | Evaluate the impact of the program on the quality of life of patients with a Physical and Mental Health Summary Scales with 12 questions (SF12) questionnaire | evaluation at the beginning of the meeting and at 9 weeks and then at 3 months |
| Pain Disability Index (PDI) | Evaluate the impact of the program on disability perceived by patients in relation to their pain: PDI questionnaire | evaluation at the beginning of the meeting and at 9 weeks and then at 3 months |
| concise questionnaire on pain short version (QCD) | Evaluation of the impact of the program on patients' pain (on daily behavior) with QCD questionnaire | evaluation at the beginning of the meeting and at 9 weeks and then at 3 months |
| Hospital Anxiety and Depression Scale (HADS) | Evaluation of the impact of the program on depression and anxiety with HADS questionnaire | evaluation at the beginning of the meeting and at 9 weeks and then at 3 months |